Thrombocytopenia identifies a severe familial phenotype of systemic lupus erythematosus and reveals genetic linkages at 1q22 and 11p13

Blood

Volumn 101, Issue 3, 2003, Pages 992-997

  Scofield, R Hal ^a   Bruner, Gail R ^a   Kelly, Jennifer A ^a   Kilpatrick, Jeff ^a   Bacino, Debra ^a   Nath, Swapan K ^a   Harley, John B ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

DNA ANTIBODY; DOUBLE STRANDED DNA; DOUBLE STRANDED DNA ANTIBODY; PHOSPHOLIPID ANTIBODY; UNCLASSIFIED DRUG;

ARTICLE; AUTOIMMUNE HEMOLYTIC ANEMIA; CHROMOSOME 11P; CHROMOSOME 1Q; DISEASE ASSOCIATION; DISEASE SEVERITY; FAMILIAL DISEASE; FEMALE; GENETIC LINKAGE; HUMAN; HUMAN TISSUE; INFLAMMATION; MAJOR CLINICAL STUDY; MALE; MENTAL DISEASE; MORTALITY; NEGRO; NEPHRITIS; NEUROLOGIC DISEASE; PEDIGREE; PHENOTYPE; PRIORITY JOURNAL; SYSTEMIC LUPUS ERYTHEMATOSUS; THROMBOCYTE COUNT; THROMBOCYTOPENIA; UNITED STATES;

EID: 0037305577     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood-2002-04-1003     Document Type: Article

References (41)

1. Tan EM, Cohen AS, Fries JF, et al. The 1982 revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum. 1982;25:1271-1277.
2. Sestak AL, Shaver TS, Moser KL, et al. Familial aggregation of lupus and autoimmunity in an unusual multiplex pedigree. J Rheumatol. 1999;26:1495-1499.
3. Hochberg MC. The application of genetic epidemiology to systemic lupus erythematosus. J Rheumatol. 1987;14:867-869.
4. Deapen D, Escalante A, Weinrib L, et al. A revised estimate of twin concordance in systemic lupus erythematosus. Arthritis Rheum. 1992;35:311-318.
5. Harley JB, Sheldon P, Neas B, et al. Systemic lupus erythematosus: considerations for a genetic approach. J Invest Dermatol. 1994;103:144S-149S.
6. Moser KL, Neas BR, Salmon JE, et al. Genome scan of human systemic lupus erythematosus: evidence for linkage on chromosome 1 q In African-American pedigrees. Proc Natl Acad Sci U S A. 1998;95:14869-14874.
7. Gaffney PM, Kearns GM, Shark KB, et al. A genome-wide search for susceptibility genes in human systemic lupus erythematosus sib-pair families. Proc Natl Acad Sci U S A. 1998;95:14875-14879.
8. Lindqvist AKB, Steinsson K, Johanneson B, et al. A susceptibility locus for human systemic lupus erythematosus (hSLE1) on chromosome 2q. J Autoimmunity. 2000;14:169-178.
9. Gaffney PM, Ortmann WA, Selby SA, et al. Genome screening in human systemic lupus erythematosus: results from a second Minnesota cohort and combined analyses of 187 sib-pair families. Am J Hum Genet. 2000;66:547-556.
10. Shai R, Quismorio FP Jr, Li L, et al. Genome-wide screen for systemic lupus erythematosus susceptibility genes in multiplex families. Hum Mol Genet. 1999;8:639-644.
11. Feinglass EJ, Arnett FC, Dorsch CA, Zizic TM, Stevens MB. Neuropsychiatric manifestations of systemic lupus erythematosus: diagnosis, clinical spectrum, and relationship to other features of the disease. Medicine (Baltimore). 1976;55:323-339.
12. Alger M, Alarcon-Segovia D, Rivero SJ. Hemolytic anemia and thrombocytopenic purpura: two related subsets of systemic lupus erythematosus. J Rheumatol. 1977;4:351-357.
13. Miller MH, Urowitz MB, Gladman DD. The significance of thrombocytopenia in systemic lupus erythematosus. Arthritis Rheum. 1983;26:1181-1186.
14. Drenkard C, Villa AR, Alarcón-Segovia D, Perez-Vazquez ME. Influence of the antiphospholipid syndrome in the survival of patients with systemic lupus erythematosus. J Rheumatol. 1994;21:1067-1072.
15. Mok CC, Lee KW, Ho CTK, Lau CS, Wong RWS. A prospective study of survival and prognostic indicators of systemic lupus erythematosus in a southern Chinese population. Rheumatology. 2000;39:399-406.
16. Reveille JD, Bartolucci A, Alarcón GS. Prognosis in systemic lupus erythematosus. Arthritis Rheum. 1990;33:37-48.
17. Pistiner M, Wallace DJ, Nessim S, Metzger AL, Klinenberg JR. Lupus erythematosus in the 1980: a survey of 570 patients. Semin Arthritis Rheum. 1991;21:55-64.
18. Abu-Shakra M, Gladman DD, Urowitz MB, Farewell V. Anticardiolipin antibodies in systemic lupus erythematosus: clinical and laboratory correlations. Am J Med. 1995;99:624-628.
19. Massardo L, Martinez ME, Jacobelli S, Villarroel L, Rosenberg H, Rivero S. Survival of Chilean patients with systemic lupus erythematosus. Sem Arthritis Rheum. 1994;24:1-11.
20. Ward MM, Pyun E, Studenski S. Mortality risks associated with specific clinical manifestations of systemic lupus erythematosus. Arch Int Med. 1996;156:1337-1344.
21. Swaak AJG, Nossent JC, Bronsveld W, et al. Systemic lupus erythematosus. I. Outcome and survival: Dutch experience with 110 patients studied prospectively. Ann Rheum Dis. 1989;48:447-454.
22. Gray-McGuire C, Moser KL, Gaffney P, et al. Genome scan of human systemic lupus erythematosus by regression modeling: evidence of linkage and epistasis at 4p16-15.2. Am J Hum Genet. 2000;67:1460-1469.
23. Moser KL, Gray-Mcguire C, Kelly J, et al. Confirmation of genetic linkage between human systemic lupus erythematosus and chromosome 1q41. Arthritis Rheum. 1999;42:1902-1907.
24. Hochberg MC. Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum. 1997;40:1725.
25. Fritzler MJ. Immunofluorescent antinuclear antibody tests. In: Rose NR, Friedman H, Fahey JL, eds. Manual of Clinical Laboratory Immunology. 3rd ed. Washington, DC: American Society for Microbiology; 1986:733-739.
26. Clark GM, Reichlin M, Tomasi TB. Characterization of a soluble cytoplasmic antigen reactive with sera from patients with systemic lupus erythematosus. J Immunol. 1968;102:117-122.
27. Harris EN, Gharavi AE, Patel SP, Hughes GR. Evaluation of the anti-cardiolipin antibody test: report of an international workshop held 4 April 1986. Clin Exp Immunol. 1987;68:215-222.
28. Olson JM. Relationship estimation by Markov-process models in a sib-pair linkage study. Am J Hum Genet. 1999;64:1464-1472.
29. S.A.G.E. Statistical analysis for genetic epidemiology, release 4.0, Beta 3 (computer package). Cleveland, OH: Department of Epidemiology and Biostatistics, Case Western Reserve University; 1999.
30. Cottingham RW Jr, Idury RM, Schäaffer AA. Faster sequential genetic linkage computations. Am J Hum Genet. 1993;53:252-263.
31. Schäffer AA, Gupta SK, Shriram K, Cottingham RW Jr. Avoiding recomputation in linkage analysis. Hum Hered. 1994;44:225-237.
32. Terwilliger JD. A powerful likelihood method for the analysis of linkage disequilibrium between trait loci and one or more polymorphic marker loci. Am J Hum Genet. 1995;56:777-787.
33. Elston RC, Buxbaum S, Jacobs KB, Olson JM. Haseman and Elston revisited. Genet Epidemiol. 2000;19:1-17.
34. Olson JM. A general conditional logistic model for affected-relative-pair linkage studies. Am J Hum Genet. 1999;65:1760-1769.
35. Goddard KAB, Witte JS, Suarez BK, Catalona WJ, Olson JM. Model-free linkage analysis with covariates confirms linkage of prostate cancer to chromosomes 1 and 4. Am J Hum Genet. 2001;68:1197-1206.
36. Lander E, Kruglyak L. Genetic dissection of complex traits: guidelines for interpreting and reporting linkage results. Nat Genet. 1995;11:241-247.
37. Kaufman KM, Kelly JA, Harley JB, Scofield RH. A genetic marker within the CD44 gene confirms linkage at 11p13 in African-American families with lupus manifested by thrombocytopenia, but association of CD44 is not present. Gene Immunity. 2002;3(suppl 1):S86-S88.
38. Venkitaraman AR. Cancer susceptibility and the functions of BRCA1 and BRCA2. Cell. 2002;108:171-182.
39. International FMF Consortium. Ancient missense mutations in a new member of the RoRet gene family are likely to cause familial Mediterranean fever. Cell. 1997;90:797-807.
40. Nath SK, Kelly JA, Namjou B, et al. Evidence for a susceptibility gene, SLEV1, on chromosome 17p13 in families with vitiligo-related systemic lupus erythematosus. Am J Hum Genet. 2001;69:1401-1406.
41. Kelly JA, Thompson K, Kilpatrick J, et al. Evidence for a susceptibility gene (SLEH1) on chromosome 11q14 for systemic lupus erythematosus families characterized by hemolytic anemia. Proc Natl Acad Sci U S A. 2002;99:11766-11771.